UFS provides advanced chemistry and drug discovery support through broad access to modern research infrastructure, including high-end analytical and characterisation instrumentation, and established laboratory capacity across analytical, inorganic, organic, and physical chemistry. UFS also maintains strong applied pathways, including a pharmaceutical R&D business unit and access to complementary campus resources such as medical faculty capabilities and drug testing facilities. UFS will lead consortium-wide impact by supporting the creation of a shared library of promising antibiotic and anticancer drug candidates, enabling joint research outputs and downstream translation.